Bombshell Vax Analysis Finds 300,000 Excess Deaths can be attributed to COVID-19 Vaccine Damages in 2022 alone

No effect or asymptomatic.

This group of individuals comprises those individuals who did not experience adverse events following the Covid-19 inoculations.  Although this group of individuals is most likely the largest, however, we cannot know for certain as to the proportion of the whole population that this group of individuals represents. We assume that these individuals are all those that are not included into the other three groups.

Because the number of individuals are likely in group two (injured) represent and estimated 18% of the population (see below), group one would amount to about 82% of the population.

Mild to moderate injury outcome

Individuals in this group are those who experienced mild to moderate adverse effects after vaccination. These adverse events could be the early sign of an injury that is temporary, long-term, or permanent in nature. Under this definition we investigated the excess rate of related adverse events in vaccinated individuals (23.90%) compared to the placebo baseline (5.98%) in the Pfizer clinical trial (reviewed here) . This is a first-order approximation for the affected population. As for the difference relative to the placebo rate, we obtain (23.90% – 5.98% = 17.92%).

The rate of adverse events in the clinical trial is corroborated by the analysis of the V-Safe database where the rate of individuals who were not able to work (but not hospitalised) after vaccination was about 29.47%. This rates includes the placebo baseline, which is unknown for the population sample of V-Safe users. They are similar to the rate of vaccine-related adverse events from the Pfizer trial.

CDC Pushed for COVID-19 Boosters Without Clinical Trials: Disturbing Emails: “Pfizer Recommends It and I Trust in their Guidance”

Taking all this evidence into consideration, we make the assumption that the pool of potentially vaccine-injured individuals is about 18% of the population, which is, the rate of related adverse events reported in the Pfizer clinical trial (minus the baseline rate).

These injuries will likely manifest a loss of productivity since, as these individuals are likely to have higher absentee rates and, consequently,higher lost worktime rates, than the pre-2019 baseline. In fact, we performed an analysis of absence rates and lost worktime rates in full time workers (using data provided by the BLS). We observed a large increase in absence rates starting in 2020, but accelerating in 2022. Absence rates in 2022 were about 28.6% higher than in 2019, representing a 11 standard deviation variation.

Severe outcome: disabilities

These individuals are easier to characterise accurately as they are associated with severe effects after vaccination, such as being disabled. Using this definition, we investigated the rise in disabilities that has occurred since the start of the vaccine rollout program, in Parts 1 to 4 of our US disabilities project.

We also investigated the excess rate of Serious and Severe Adverse Events in vaccinated individuals compared to the placebo baseline in the Pfizer and Moderna clinical trials (here), and the Severe Adverse Events in the Pfizer trial. This was then compared with the rise in disabilities at the population level (Part 5 and Part 6).

“Toxic Nanoforms inside Pfizer-Biontech Covid Vaccine”. Vital Study by Italian Biochemist on US Journal of Virology highlights an Alleged Crime

Furthermore, the rate of hospitalisation with five or more days of lost work derived from the V-Safe database, corroborates at a population level our computations of time-series of Serious and Severe Adverse Events.

Death – Extreme outcome

This group of individuals died as a consequence of vaccination. We compute excess mortality estimates using our method 2C, as described in our methodology report (here), providing an estimate of the extent of the Covid-19 pandemic’s damage.

At the population level, deaths caused by Covid-19 vaccinations and other causes of death are not easily distinguished. For example, in older individuals, excess mortality could be driven substantially by Covid-19, while in younger individuals the increase in fentanyl overdoses or other causes could play a role.

Cleveland Clinic: “Higher Risk of COVID-19 Infection among Vaccinated”. Israeli Study on SARS-Breakthrough, Killer according to CDC Data

Starting in the summer of 2021, however, with the introduction of mass vaccinations, the rise in natural immunity by exposure to the virus, and the emergence of milder and more contagious virus strains such as Omicron, it is difficult to argue if Covid-19 had a significant role in excess mortality.

Therefore, we can use the total excess mortality in 2021 and 2022 as an estimate for vaccine-related deaths, or at least an estimated upper limit for the vaccine damage. We compute excess mortality estimates using our method 2C, as described in our methodology report (here).

The analysis of excess mortality for 2020, 2021 and 2022 can be visualised in the interactive charts (here).

Conclusions